S-1 registration and Nasdaq readiness
Disclosure drafting, risk factors, MD&A, governance review, SEC comment response.

BGo is Bandi LLP's capital markets platform for issuers preparing for IPOs, S-1 and F-1 registration statements, OTC Markets applications, public-company readiness, SEC review, exchange listing, and post-listing compliance.
WHY BGO
BGo helps issuers convert business, financial and risk information into public-company disclosure that can withstand SEC review, investor diligence and board-level scrutiny.
Public-market transactions require coordinated work across auditors, underwriters, placement agents, market makers, transfer agents, EDGAR providers, exchanges, OTC Markets and internal management teams.
Going public is not the end of the process. BGo helps companies prepare for reporting calendars, governance requirements, insider controls, disclosure policies and ongoing compliance.
SERVICES
S-1 / F-1 GUIDE
Explain the company's operating model, products and services, markets, revenue drivers, competitive position, strategy, material contracts and regulatory environment.
PROCESS
Review the issuer's corporate structure, financial statements, capitalization, governance, material contracts, related-party arrangements and potential public-market path.
Build a transaction workplan, diligence request list, disclosure responsibility matrix, filing calendar and coordination process among counsel, auditors and financial advisers.
Prepare the S-1, F-1, OTC disclosure package or other market-entry documents, including risk factors, business description, MD&A, governance disclosure and exhibits.
Coordinate SEC submission or filing, comment-response strategy, OTC Markets review, exchange comments and revised disclosure drafts.
Support effectiveness, quotation, listing, closing mechanics, EDGAR filings, press releases, board approvals and first-trade readiness.
Implement reporting calendars, board processes, insider policies, disclosure controls, earnings-cycle planning and ongoing compliance support.
TIMELINE
| Phase | Indicative duration | Key dependencies |
|---|---|---|
| Readiness review | 1–3 weeks | Depends on corporate records, audit status and transaction path. |
| Drafting and diligence | 4–8 weeks | Depends on financial statements, management input, diligence materials and adviser coordination. |
| SEC review | 30–90+ days | Depends on SEC comment volume, filing cadence and disclosure complexity. |
| OTC Markets / exchange process | Timing varies | Depends on market-maker, OTC Markets, exchange and eligibility requirements. |
| Post-listing compliance | Ongoing | Requires reporting calendar, governance controls and disclosure procedures. |
CHECKLIST
Work through the readiness items below. This checklist is for orientation only and does not save your responses.
0 / 25
REPRESENTATIVE EXPERIENCE
Disclosure drafting, risk factors, MD&A, governance review, SEC comment response.
Foreign private issuer analysis, cross-border disclosure, financial statement coordination, SEC amendments.
OTC Markets review, disclosure package, market-maker coordination, attorney letter support where applicable.
Exchange standards, capitalization planning, governance remediation, public-company policies.
Selling shareholder disclosure, Rule 144 analysis, exhibit collection, SEC filing support.
Reporting calendar, board process, insider controls, Form 10-K / 20-F planning.
BGO BY THE NUMBERS
TEAM
BGo is delivered by Bandi LLP's Capital Markets & Securities team across New York, Tokyo and San Francisco.
Partner, Capital Markets & Securities
Partner, Capital Markets & Securities
Associate, Banking & Finance
Partner, Mergers & Acquisitions
Partner, Capital Markets & Securities
Partner, Data, Technology & Privacy
Associate, Data, Technology & Privacy
FAQ
No. BGo supports IPOs, F-1 registrations, S-1 registrations, OTC Markets applications, uplisting readiness, resale registrations and public-company compliance planning.
Companies should start before they need to file. Audit readiness, corporate records, related-party transactions, governance structure and disclosure controls often determine timing.
Yes. BGo supports foreign private issuers preparing Form F-1 filings and related cross-border disclosure, governance and financial-statement workstreams.
No. Timing, SEC review, OTC Markets review, exchange review and market outcomes depend on many factors. Prior results do not guarantee a similar outcome.
Form S-1 is generally used by domestic U.S. issuers. Form F-1 is generally used by eligible foreign private issuers. The correct form depends on the issuer's status and facts.
Yes. BGo supports ongoing reporting, disclosure controls, board calendars, insider policies, Form 10-K, Form 10-Q, Form 8-K, proxy matters and other compliance needs.
BGo gives management teams a structured way to understand the path, identify gaps and move toward filing with discipline.